{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:56:20Z","timestamp":1784728580525,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["ZYXPY2024-005"],"award-info":[{"award-number":["ZYXPY2024-005"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118169","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T11:52:56Z","timestamp":1758023576000},"page":"118169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synthesis and biological evaluation of C-28-modified pyrazole-fused betulinic acid derivatives as potent antiosteoporosis agents"],"prefix":"10.1016","volume":"300","author":[{"given":"Tianzhen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enqi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-Guang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9552-519X","authenticated-orcid":false,"given":"Liang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118169_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cdtm.2015.02.006","article-title":"Primary osteoporosis in postmenopausal women","volume":"1","author":"Ji","year":"2015","journal-title":"Chronic Diseases and Translational Medicine"},{"key":"10.1016\/j.ejmech.2025.118169_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJM199502023320506","article-title":"Cytokines, and bone remodeling \u2014 emerging insights into the pathophysiology of osteoporosis","volume":"332","author":"Manolagas Stavros","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118169_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104944","article-title":"Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation","volume":"159","author":"Chen","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.118169_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13346-022-01222-6","article-title":"Bone regeneration in osteoporosis: opportunities and challenges","volume":"13","author":"Patel","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejmech.2025.118169_bib5","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/np500417d","article-title":"Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-\u03baB, c-fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway","volume":"77","author":"Huh","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118169_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069468","article-title":"KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: roles of MAPKs, Akt, NF-\u03baB and calcium\/calcineurin\/NFATc1 pathways","volume":"8","author":"Liou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118169_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2025.118169_bib8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ejmech.2025.118169_bib9","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/bcp.13867","article-title":"Pharmacology of bisphosphonates","volume":"85","author":"Cremers","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118169_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91248-6","article-title":"Denosumab versus romosozumab for postmenopausal osteoporosis treatment","volume":"11","author":"Kobayakawa","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118169_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108568","article-title":"Structures and biological activities of anti-osteoporotic drugs: an overview of promising small-molecule therapeutics for the treatment of osteoporosis","volume":"162","author":"Wen","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2017.03.008","article-title":"Synthesis of heterocyclic ring-fused tricyclic diterpene analogs as novel inhibitors of RANKL-induced osteoclastogenesis and bone resorption","volume":"131","author":"Wei","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib13","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/acs.jmedchem.4c00349","article-title":"Synthesis of heterocyclic ring-fused bisnoralcohol derivatives as novel small-molecule antiosteoporosis agents","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib14","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1021\/jm5002293","article-title":"Tryptophan hydroxylase 1 (Tph-1)-Targeted bone anabolic agents for osteoporosis","volume":"57","author":"Fu","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib15","doi-asserted-by":"crossref","first-page":"15738","DOI":"10.1021\/acs.jmedchem.4c01377","article-title":"Discovery of novel neo-clerodane derivatives as potent dual-functional antiosteoporosis agents through targeting peroxisome proliferator-activated receptor-\u03b3","volume":"67","author":"Peng","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib16","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1021\/acs.jmedchem.3c00601","article-title":"Synthesis and biological evaluation of heterocyclic ring-fused 20(S)-Protopanaxadiol derivatives as potent antiosteoporosis agents","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fitote.2019.02.028","article-title":"Triterpenoids from Euphorbia pulcherrima with inhibitory effects on osteoclastogenesis","volume":"134","author":"Dai","year":"2019","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2025.118169_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biochi.2015.02.002","article-title":"Inhibitory effects of ursolic acid on osteoclastogenesis and titanium particle-induced osteolysis are mediated primarily via suppression of NF-\u03baB signaling","volume":"111","author":"Jiang","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2025.118169_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bone.2013.12.013","article-title":"Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLC\u03b32\u2013Ca2+-NFATc1 signaling, and suppresses bone loss in mice","volume":"60","author":"Kim","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.ejmech.2025.118169_bib20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/acs.jnatprod.5b01088","article-title":"Lupeol isolated from sorbus commixta suppresses 1\u03b1,25-(OH)2D3-Mediated osteoclast differentiation and bone loss in vitro and in vivo","volume":"79","author":"Im","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.118169_bib21","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1476-5381.2012.02059.x","article-title":"The antinociceptive triterpene \u03b2-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors","volume":"167","author":"Chicca","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118169_bib22","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1021\/jm201540h","article-title":"Synthesis and biological evaluation of heterocyclic ring-fused betulinic acid derivatives as novel inhibitors of osteoclast differentiation and bone resorption","volume":"55","author":"Xu","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib23","doi-asserted-by":"crossref","first-page":"39436","DOI":"10.1039\/D4RA07602H","article-title":"Construction, structural modification, and bioactivity evaluation of pentacyclic triterpenoid privileged scaffolds in active natural products","volume":"14","author":"Zeng","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118169_bib24","doi-asserted-by":"crossref","first-page":"13676","DOI":"10.1021\/acs.jmedchem.1c01019","article-title":"Synthesis and biological evaluation of C-17-Amino-Substituted pyrazole-fused betulinic acid derivatives as novel agents for osteoarthritis treatment","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejmech.2015.05.015","article-title":"Discovery of 5-(2\u2032,4\u2032-difluorophenyl)-salicylanilides as new inhibitors of receptor activator of NF-\u03baB ligand (RANKL)-induced osteoclastogenesis","volume":"98","author":"Lee","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116499","article-title":"Mechanisms of bone resorption","volume":"163","author":"Everts","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.ejmech.2025.118169_bib27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","article-title":"Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group","volume":"14","author":"Black","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejmech.2025.118169_bib28","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1021\/jm502014h","article-title":"Novel pyrazole derivatives effectively inhibit osteoclastogenesis, a potential target for treating osteoporosis","volume":"58","author":"Kuo","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ejmech.2016.08.004","article-title":"Synthesis and biological evaluation of rhein amides as inhibitors of osteoclast differentiation and bone resorption","volume":"123","author":"Xu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib30","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1021\/jm5007897","article-title":"Modified Salicylanilide and 3-Phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione Derivatives as Novel Inhibitors of Osteoclast Differentiation and Bone Resorption","volume":"57","author":"Chen","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118169_bib31","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1021\/jm201540h","article-title":"Synthesis and biological evaluation of heterocyclic ring-fused betulinic acid derivatives as novel inhibitors of osteoclast differentiation and bone resorption","volume":"55","author":"Xu","year":"2012","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:52:30Z","timestamp":1773114750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S0223523425009341"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118169","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of C-28-modified pyrazole-fused betulinic acid derivatives as potent antiosteoporosis agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118169"}}